Boxer Capital’s BioAtla BCAB Stock Holding History

Boxer Capital’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,727	Closed	-$1.21M	–	8
2024 Q3	$1.21M	Hold	13,727	–	–	0.06%	64
2024 Q2	$940K	Hold	13,727	–	–	0.05%	57
2024 Q1	$2.36M	Hold	13,727	–	–	0.12%	53
2023 Q4	$1.69M	Hold	13,727	–	–	0.08%	44
2023 Q3	$1.17M	Hold	13,727	–	–	0.06%	61
2023 Q2	$2.06M	Hold	13,727	–	–	0.1%	66
2023 Q1	$1.84M	Hold	13,727	–	–	0.09%	68
2022 Q4	$5.66M	Hold	13,727	–	–	0.3%	48
2022 Q3	$5.29M	Hold	13,727	–	–	0.3%	52
2022 Q2	$1.96M	Hold	13,727	–	–	0.12%	68
2022 Q1	$3.45M	Hold	13,727	–	–	0.18%	62
2021 Q4	$13.5M	Hold	13,727	–	–	0.52%	42
2021 Q3	$20.2M	Hold	13,727	–	–	0.71%	40
2021 Q2	$29.1M	Hold	13,727	–	–	1.03%	26
2021 Q1	$34.9M	Hold	13,727	–	–	1.18%	26
2020 Q4	$23.3M	Buy	+13,727	New	+$22.9M	0.75%	37

Other funds holding BCAB

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Boxer Capital's BCAB Position: Q4 2024 in Review

Boxer Capital sold out of BioAtla (BCAB) in Q4 2024, closing a stake of 13,727 shares — an estimated $1.21M sold.

Boxer Capital first reported a position in BCAB in Q4 2020 and held it in 16 quarters. The position peaked at $34.9M in Q1 2021. 67 funds tracked by Wall St. Rank hold BCAB as of Q4 2024.

Boxer Capital reported no remaining BioAtla position as of Q4 2024 after selling out during the quarter.
Boxer Capital sold 13,727 BioAtla shares in Q4 2024, an estimated $1.21M.
Boxer Capital first reported a position in BioAtla in Q4 2020 and held it in 16 quarters.
Boxer Capital's BioAtla position peaked at $34.9M in Q1 2021.
67 funds tracked by Wall St. Rank held BioAtla as of Q4 2024.

Based on Boxer Capital's 13F filing for Q4 2024.